Management of Atrial fibriLLation INcluding tailoring of anticoagulation in patients from primary care - ALL-I
- Conditions
- abnormal heart rhythma-fib10007521
- Registration Number
- NL-OMON44028
- Lead Sponsor
- Isala Klinieken Zwolle
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 1000
patients with atrial fibrillation of whom the GPs will provide integral management of AF and 65 years and over.
-unwilling to provide informed consent by the general practitioner
-life expectancy less than 3 months
-have an internal ICD or or a Cardiac Resynchronisation Therapy (CRT) device
-had a cardiac resynchronization treatment, cardiac ablation or cardiac surgery less than 3 months prior to inclusion, or one of these procedures planned
-heart valve surgery in the past
-a rheumatic mitral valve stenosis
-pulmonary vein isolation in the past, or planned
-if they are legally incapable of providing informed consent for the intervention program
-if they participate in another randomized trial about AF
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Main study parameter/endpoint:<br /><br>The primary outcome for this study is all-cause mortality during the study<br /><br>duration of 24 months.<br /><br><br /><br><br /><br><br /><br></p><br>
- Secondary Outcome Measures
Name Time Method